Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenge Zhu

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Aging|February 3, 2017
MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysisTian Tian, Meng Wang, Wenge Zhu, et al.
Cancer Research|August 22, 2019
The Cdk2-c-Myc-miR-571 Axis Regulates DNA Replication and Genomic Stability by Targeting GemininYi Zhang, Zhuqing Li, Qiang Hao, et al.
Clinical and Translational Medicine|December 19, 2021
Discovery and characterization of potent And-1 inhibitors for cancer treatmentJing Li, Yi Zhang, Jing Sun, et al.
Scientific Reports|December 21, 2021
Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Scientific Reports|February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Nature Communications|April 13, 2026
Author Correction: O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancerYi Zhang, Shuyan Zhou, Yan Kai, et al.
Nature Communications|March 16, 2019
The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitorsYihan Peng, Qingchao Liao, Wei Tan, et al.
Nature Communications|July 3, 2024
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancerYi Zhang, Shuyan Zhou, Yan Kai, et al.
Cancer Research|February 12, 2025
Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast CancerShuyan Zhou, Yi Zhang, Julie Belmar, et al.
Molecular Cell|March 3, 2021
Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylationWei Tan, Pei Jiang, Wanjun Zhang, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Aging|February 3, 2017
MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysisTian Tian, Meng Wang, Wenge Zhu, et al.
Cancer Research|August 22, 2019
The Cdk2-c-Myc-miR-571 Axis Regulates DNA Replication and Genomic Stability by Targeting GemininYi Zhang, Zhuqing Li, Qiang Hao, et al.
Clinical and Translational Medicine|December 19, 2021
Discovery and characterization of potent And-1 inhibitors for cancer treatmentJing Li, Yi Zhang, Jing Sun, et al.
Scientific Reports|December 21, 2021
Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Scientific Reports|February 28, 2020
Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancerSara Moufarrij, Aneil Srivastava, Stephanie Gomez, et al.
Nature Communications|April 13, 2026
Author Correction: O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancerYi Zhang, Shuyan Zhou, Yan Kai, et al.
Nature Communications|March 16, 2019
The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitorsYihan Peng, Qingchao Liao, Wei Tan, et al.
Nature Communications|July 3, 2024
O-GlcNAcylation of MITF regulates its activity and CDK4/6 inhibitor resistance in breast cancerYi Zhang, Shuyan Zhou, Yan Kai, et al.
Cancer Research|February 12, 2025
Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast CancerShuyan Zhou, Yi Zhang, Julie Belmar, et al.
Molecular Cell|March 3, 2021
Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylationWei Tan, Pei Jiang, Wanjun Zhang, et al.
Pageof 6